Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis

This study has been completed.

Study NCT00770913 Information provided by Eisai Inc.

First Received: October 9, 2008 Last Updated: June 1, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2010
Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)